GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $7,000 | +16.7% | 4,001 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | 0.0% | 4,001 | +7.8% | 0.00% | – |
| Q4 2014 | $6,000 | -25.0% | 3,711 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | -20.0% | 3,711 | +12.4% | 0.00% | – |
| Q2 2014 | $10,000 | +25.0% | 3,301 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | -50.0% | 3,301 | 0.0% | 0.00% | – |
| Q4 2013 | $16,000 | – | 3,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 314,900 | $147,000 | 0.03% |
| EQUITEC SPECIALISTS, LLC | 120,300 | $56,000 | 0.01% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 39,000 | $18,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,593,277 | $743,000 | 0.01% |
| Aspen Investment Management Inc | 15,000 | $7,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 966,068 | $450,000 | 0.01% |
| Acrospire Investment Management LLC | 11,300 | $5,000 | 0.00% |
| SABBY MANAGEMENT, LLC | 113,530 | $53,000 | 0.00% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $5,000 | 0.00% |
| ACG Wealth | 25,000 | $12,000 | 0.00% |